Cargando...
The impact of glucose-lowering medications on cardiovascular disease
Patients with type 2 diabetes mellitus die most frequently from cardiovascular disease. Metabolic control is mandatory both for preventing long-term complications and for reducing the negative effects of the exposure of the other risk factors. In this article, we will describe the most commonly used...
Gardado en:
| Publicado en: | Cardiovasc Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wolters Kluwer Health
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6739886/ https://ncbi.nlm.nih.gov/pubmed/31646273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/XCE.0000000000000139 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|